What is a commonly recommended practice when initiating GLP-1 receptor agonists to minimize GI side effects?

What is a commonly recommended practice when initiating GLP-1 receptor agonists to minimize GI side effects?

• A. Start at full dose
• B. Stop therapy if GI symptoms occur
• C. Gradually titrate to full maintenance dose
• D. Switch to oral formulation immediately

Answer: (C)

Starting GLP-1 receptor agonists with a gradual dose increase helps the gut adapt to the drug’s effects on gastric emptying and appetite. Because these medications commonly cause nausea, fullness, and related GI symptoms, introducing a smaller initial dose and slowly ramping up to the full maintenance dose reduces the intensity and duration of side effects, improving tolerability and adherence. Over time, many patients tolerate the full dose as tolerance develops. The other options would raise the likelihood of bothersome GI symptoms or don’t address the tolerance build-up you want when initiating therapy.

Starting GLP-1 receptor agonists with a gradual dose increase helps the gut adapt to the drug’s effects on gastric emptying and appetite. Because these medications commonly cause nausea, fullness, and related GI symptoms, introducing a smaller initial dose and slowly ramping up to the full maintenance dose reduces the intensity and duration of side effects, improving tolerability and adherence. Over time, many patients tolerate the full dose as tolerance develops. The other options would raise the likelihood of bothersome GI symptoms or don’t address the tolerance build-up you want when initiating therapy.